This Australian medicinal cannabis cultivator is leading the industry with a disruptive, cost-effective, and high-quality approach to production. As the first hybrid indoor/outdoor, year-round cultivator in Australia, the company selects superior cannabis genetics to produce premium flower and biomass at some of the industry’s most competitive prices.
Key Highlights
- Innovative Cultivation Model: Utilizing a unique, year-round indoor-outdoor hybrid cultivation process, the company ensures a consistent supply of high-quality cannabis flower that offers exceptional value.
- Extensive Scale and Capacity: Operating on a 12-acre footprint, the facility can yield up to 41 tonnes of medicinal cannabis annually. With 24 harvests per year, the company guarantees an uninterrupted supply of premium product.
- Ultra-Low Production Costs: The company has achieved industry-leading low production costs, even outperforming black market prices, enabling them to offer high-quality products at competitive rates.
- Exclusive Genetics & Expert Team: Guided by a robust management team and an extensive breeding program, the company maintains exclusive genetics and stays at the forefront of market trends.
- Strong Market Position & Partnerships: Already holding key licenses (Medicinal Cannabis Licence) and with established relationships with exporters, the company has secured supply pathways into the UK and EU, supported by signed off-take agreements.
- First Organic Outdoor-Hybrid Producer: Poised to become one of Australia’s first and largest organic outdoor-hybrid medicinal cannabis producers, the company capitalizes on outdoor cultivation to enhance terpene and cannabinoid profiles, providing a superior product experience for patients.
- Strategic Growth Potential: With clear plans to scale operations potentially up to 100 acres, the company is prepared to significantly increase market share and meet growing demand.
- Diverse Commercial Pathways: The company has defined profitable commercial pathways for both its flower and biomass derivatives. From fresh frozen live rosin to other finished products, they maintain strong and sustainable margins.
Investment Opportunity
- Seeking Investment: The company is seeking a strategic investment of AUD $3.5 million.
- Use of Funds: The investment will be used to fully activate their production capacity, streamline operations, and facilitate market entry, positioning the company as a dominant force in the Australian medicinal cannabis market.
An exceptional investment opportunity awaits with this leading Australian medical cannabis cultivator. A strategic investment of $3.5 million AUD will enable full production capacity, positioning it to capture a substantial share of the growing global market.
